625446-33-5

Upstream product

• 5382-16-1 4-HYDROXYPIPERIDINE 
• 586-75-4 4-chlorobenzoyl chloride 
• 586-76-5 4-Bromobenzoic acid 

Downstream Products

• 1373334-96-3 (E)-(4-bromophenyl)(4-(but-2-enyl)piperidin-1-yl)methanone 
• 1373334-77-0 (4-bromophenyl)(4-iodopiperidin-1-yl)methanone 
• 1100094-82-3 (4-hydroxypiperidin-1-yl) (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone 

Relevant academic research and scientific papers

Polymerizable compounds and their use in a liquid crystal display

The present invention relates to polymerisable compounds comprising a carboxamide or sulphonamide group, to processes and intermediates for the preparation thereof, to liquid-crystal (LC) media comprising them, and to the use of the polymerisable compound

Delta opiate receptor antagonist, application thereof and medicine composition

The invention discloses a compound with a structure shown as a general formula (I) (the general formula is shown in the description), a pharmaceutical salt, hydrate or metabolite formed through metabolism in any form, application of the compound with the

Ni-catalyzed reductive allylation of unactivated alkyl halides with allylic carbonates

Game of two electrophiles: Two partially positively charged sp3 carbon atoms can be connected by using a catalytic Ni species in the presence of an environmentally benign Zn reductant, delivering allylated alkanes (see scheme). This unprecedent

INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME

Compounds of formula (I) are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.